Last edition
News about "SPC-15"
Silo Pharma Receives Canadian Patent Allowance for Novel PTSD Treatment
Silo Pharma receives a Notice of Allowance for its Canadian patent application covering a novel Post-Traumatic Stress Disorder (PTSD) treatment, strengthening its global Intellectual Property (IP) portfolio.
SPC-15 | 19/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members